EUCTR2017-002571-25-BE进行中（未招募）1 期
A comparison between corifollitropin alfa and recombinant FSH for follicular recruitment in women with polycystic ovaries who undergo IVM treatment - Optimisation of follicular recruitment in IVM cycles
Z Brussel0 个研究点目标入组 145 人开始时间: 2017年8月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 145
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1.Subfertile patients between 18–36 years old eligible for ART treatment
- •2.BMI 18-30
- •3.Polycystic ovarian morphology of the ovaries (PCO) according to the Rotterdam criteria (at least 12 antral follicles per ovary as observed on a baseline ultrasound scan), with or without hyperandrogenism, with or without oligoamenorrhoea. In other words, patients are eligible if they have PCO morphology. A diagnosis of PCOS based on Rotterdam criteria is not compulsory.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 145
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Antral follicle count (AFC) <24
- •2.Anti-müllerian hormone (AMH) <3,25 in non-OCP users and <4,00 in current OCP users (using Elecsys platform (Roche Diagnostics))
- •3.Couples requesting PGD
- •4.Non-obstructive azoospermia in the male partner
研究者
相似试验
招募中
3 期
evaluation the effect of Alnavar drug on patients with low ovarian reserve in ivf cyclediminished ovarian reserve in IVF cycle.Female infertility of other originN97.8IRCT20221016056198N1Shahid Beheshti University of Medical Sciences90
进行中（未招募）
1 期
COrifollitropin alfa followed by Menotropin for Poor Ovarian Responders TrialInfertility in women with poor ovarian response to stimulation for IVF/ICSIEUCTR2013-000583-29-BEniversitair Ziekenhuis Brussel150
已完成
3 期
Optimisation of Follicular Recruitment in IVM CyclesInfertility, FemalePolycystic Ovary SyndromeNCT03197077Universitair Ziekenhuis Brussel145
进行中（未招募）
1 期
sefulness of Corifollitropin alfa as alternative to conventional daily rFSH protocols in oocyte donors undergoing pituitary suppression with Medroxiprogesterona acetate (MPA).CTIS2023-506908-66-00Ivi Valencia S.L.318
进行中（未招募）
1 期
Corifolitropin alfa for double ovarian stimulation in low respondersEUCTR2018-003484-56-ESMiguel Caballero Campo292